About Standard Diagnostic
Standard Diagnostic is a Healthcare company based in Suwon (South Korea) founded in 1999, and was acquired by Alere in February 2013. Developer of diagnostic tests to diagnose diseases such as Malaria, Dengue, HIV and Syphilis at earlier stages. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified.
Company details
Standard Diagnostics develops rapid diagnostics tests to diagnose diseases such as malaria, dengue, blood-borne diseases, HIV, Tuberculosis, gastrointestinal infections, tropical diseases, febrile diseases, and other respiratory and infectious diseases at earlier stages. Its primary products include SD BIOLINE HIVSyphilis Duo which received WHO prequalification. It is designed to detect both dengue virus NS1 antigen and antibodies to Dengue virus (Dengue IgGIgM) in human serum, plasma, or whole blood. Additionally, it also provides ELISA tests, urine strips, and urine analyzers.
- Headquarters Suwon, South Korea
- Stage Acquired
- SectorsHealthcare
- Website standardia.com
- Acquired by Alere (Feb 2013)
Investors in Standard Diagnostic
Standard Diagnostic has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alere.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of small rapid diagnostic devices for infectious diseases | 1991 | alere.com | Waltham, United States |
Investor details for Standard Diagnostic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Standard Diagnostic
2 dated milestones of Standard Diagnostic across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Standard Diagnostic is founded.
- Exit Acquired by Alere.
Web traffic of Standard Diagnostic
Websites that share an audience with Standard Diagnostic (standardia.com).
Websites whose visitors overlap most with Standard Diagnostic. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novatec-id.com | 100% | View details | |||
| diatron.com | 88% | 2.2K | #6,052,304 | View details | |
| spinreact.com | 88% | 18.2K | #1,431,441 | View details | |
improve-medical.com | improve-medical.com | 88% | – | ||
| aptaca.com | 88% | #4,819,910 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Standard Diagnostic
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Standard Diagnostic
Standard Diagnostic was founded in 1999.
Standard Diagnostic is headquartered in Suwon, South Korea. It is registered at Suwon, Gyeonggi, South Korea.
Standard Diagnostics develops rapid diagnostics tests to diagnose diseases such as malaria, dengue, blood-borne diseases, HIV, Tuberculosis, gastrointestinal infections, tropical diseases, febrile diseases, and other respiratory and infectious diseases at earlier stages. Its primary products include SD BIOLINE HIVSyphilis Duo which received WHO prequalification. It is designed to detect both dengue virus NS1 antigen and antibodies to Dengue virus (Dengue IgGIgM) in human serum, plasma, or whole blood. Additionally, it also provides ELISA tests, urine strips, and urine analyzers.
Standard Diagnostic has 1 investor. Key investors include Alere.
Yes. Standard Diagnostic was acquired by Alere in February 2013.